British Journal of Cancer - Table of Contents alert Volume 116 Issue 9

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 116, Issue 9 (1119-1246) Published online 25 April 2017 In this issue Review Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Follow us on Twitter Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach Maria J Bueno, Silvana Mouron and Miguel Quintela-Fandino Br J Cancer 2017 116: 1119-1125; advance online publication, March 16, 2017; 10.1038/bjc.2017.69 Abstract | Full Text Clinical Studies Top First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers Eric Angevin, Nicolas Isambert, Véronique Trillet-Lenoir, Benoit You, Jérôme Alexandre, Gérard Zalcman, Philippe Vielh, Françoise Farace, Fanny Valleix, Thomas Podoll, Yu Kuramochi, Itaru Miyashita, Osamu Hosono, Nam H Dang, Kei Ohnuma, Taketo Yamada, Yutaro Kaneko and Chikao Morimoto Br J Cancer 2017 116: 1126-1134; advance online publication, March 14, 2017; 10.1038/bjc.2017.62 Abstract | Full Text Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and the Tenon score. Results of the NOTEGS study Roman Rouzier, Catherine Uzan, Alexandra Rousseau, Eugénie Guillot, Sonia Zilberman, Charles Meyer, Pablo Estevez, Pierre-Francois Dupre, David Kere, Virginie Doridot, Gauthier D'halluin, Xavier Fritel, Nicolas Pouget, Clémentine Jankowski, Chafika Mazouni, Tabassome Simon and Charles Coutant Br J Cancer 2017 116: 1135-1140; advance online publication, March 21, 2017; 10.1038/bjc.2017.47 Abstract | Full Text Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy Adi Nosrati, Katy K Tsai, Simone M Goldinger, Paul Tumeh, Barbara Grimes, Kimberly Loo, Alain P Algazi, Thi Dan Linh Nguyen-Kim, Mitchell Levesque, Reinhard Dummer, Omid Hamid and Adil Daud Br J Cancer 2017 116: 1141-1147; advance online publication, March 21, 2017; 10.1038/bjc.2017.70 Abstract | Full Text Does emergency presentation of cancer represent poor performance in primary care? Insights from a novel analysis of linked primary and secondary care data Peter Murchie, Sarah M Smith, Michael S Yule, Rosalind Adam, Melanie E Turner, Amanda J Lee and Shona Fielding Br J Cancer 2017 116: 1148-1158; advance online publication, March 23, 2017; 10.1038/bjc.2017.71 Abstract | Full Text The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy Lucy A M Simmons, Abi Kanthabalan, Manit Arya, Tim Briggs, Dean Barratt, Susan C Charman, Alex Freeman, James Gelister, David Hawkes, Yipeng Hu, Charles Jameson, Neil McCartan, Caroline M Moore, Shonit Punwani, Navin Ramachandran, Jan van der Meulen, Mark Emberton and Hashim U Ahmed Br J Cancer 2017 116: 1159-1165; advance online publication, March 28, 2017; 10.1038/bjc.2017.57 Abstract | Full Text Translational Therapeutics Top Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy Amir Faisal, Grace W Y Mak, Mark D Gurden, Cristina P R Xavier, Simon J Anderhub, Paolo Innocenti, Isaac M Westwood, Sébastien Naud, Angela Hayes, Gary Box, Melanie R Valenti, Alexis K De Haven Brandon, Lisa O'Fee, Jessica Schmitt, Hannah L Woodward, Rosemary Burke, Rob L M vanMontfort, Julian Blagg, Florence I Raynaud, Suzanne A Eccles, Swen Hoelder and Spiros Linardopoulos Br J Cancer 2017 116: 1166-1176; advance online publication, March 23, 2017; 10.1038/bjc.2017.75 Abstract | Full Text High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients Tuya Bai, Takehiko Yokobori, Bolag Altan, Munenori Ide, Erito Mochiki, Mitsuhiro Yanai, Akiharu Kimura, Norimichi Kogure, Toru Yanoma, Masaki Suzuki, Pinjie Bao, Kyoichi Kaira, Takayuki Asao, Ayaka Katayama, Tadashi Handa, Navchaa Gombodorj, Masahiko Nishiyama, Tetsunari Oyama, Kyoichi Ogata and Hiroyuki Kuwano Br J Cancer 2017 116: 1177-1185; advance online publication, March 23, 2017; 10.1038/bjc.2017.76 Abstract | Full Text Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer Karuna Mittal, Shashi Donthamsetty, Ramneet Kaur, Chunhua Yang, Meenakshi V Gupta, Michelle D Reid, Da Hoon Choi, Padmashree C G Rida and Ritu Aneja Br J Cancer 2017 116: 1186-1194; advance online publication, March 23, 2017; 10.1038/bjc.2017.78 Abstract | Full Text SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour Olli-Pekka Pulkka, Bengt Nilsson, Maarit Sarlomo-Rikala, Peter Reichardt, Mikael Eriksson, Kirsten Sundby Hall, Eva Wardelmann, Aki Vehtari, Heikki Joensuu and Harri Sihto Br J Cancer 2017 116: 1195-1202; advance online publication, March 23, 2017; 10.1038/bjc.2017.82 Abstract | Full Text LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma Sei Naito, Peter Makhov, Igor Astsaturov, Konstantin Golovine, Alexei Tulin, Alexander Kutikov, Robert G Uzzo and Vladimir M Kolenko Br J Cancer 2017 116: 1203-1207; advance online publication, March 28, 2017; 10.1038/bjc.2017.77 Abstract | Full Text Molecular Diagnostics Top MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue Hormas Ghadially, Lee Brown, Chris Lloyd, Leeanne Lewis, Arthur Lewis, Janette Dillon, Richard Sainson, Jelena Jovanovic, Natalie J Tigue, David Bannister, Lisa Bamber, Viia Valge-Archer and Robert W Wilkinson Br J Cancer 2017 116: 1208-1217; advance online publication, March 23, 2017; 10.1038/bjc.2017.79 Abstract | Full Text Human papillomavirus 16 is an aetiological factor of scrotal cancer Núria Guimerà, Laia Alemany, Gordana Halec, Michael Pawlita, Gerard Vincent Wain, José Santos Salas Vailén, Jerome E Azike, David Jenkins, Silvia de Sanjosé, Wim Quint and F Xavier Bosch Br J Cancer 2017 116: 1218-1222; advance online publication, April 4, 2017; 10.1038/bjc.2017.74 Abstract | Full Text Epidemiology Top Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium Suzanne C Dixon, Christina M Nagle, Nicolas Wentzensen, Britton Trabert, Alicia Beeghly-Fadiel, Joellen M Schildkraut, Kirsten B Moysich, Anna deFazio, Australian Ovarian Cancer Study Group, Harvey A Risch, Mary Anne Rossing, Jennifer A Doherty, Kristine G Wicklund, Marc T Goodman, Francesmary Modugno, Roberta B Ness, Robert P Edwards, Allan Jensen, Susanne K Kjær, Estrid Høgdall, Andrew Berchuck, Daniel W Cramer, Kathryn L Terry, Elizabeth M Poole, Elisa V Bandera, Lisa E Paddock, Hoda Anton-Culver, Argyrios Ziogas, Usha Menon, Simon A Gayther, Susan J Ramus, Aleksandra Gentry-Maharaj, Celeste Leigh Pearce, Anna H Wu, Malcolm C Pike and Penelope M Webb on behalf of the Ovarian Cancer Association Consortium Br J Cancer 2017 116: 1223-1228; advance online publication, March 28, 2017; 10.1038/bjc.2017.68 Abstract | Full Text Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer Jing Shen, Yuyan Liao, John L Hopper, Mandy Goldberg, Regina M Santella and Mary Beth Terry Br J Cancer 2017 116: 1229-1233; advance online publication, March 28, 2017; 10.1038/bjc.2017.81 Abstract | Full Text Acid-suppressing therapies and subsite-specific risk of stomach cancer E Christina M Wennerström, Jacob Simonsen, M Constanza Camargo and Charles S Rabkin Br J Cancer 2017 116: 1234-1238; advance online publication, March 28, 2017; 10.1038/bjc.2017.84 Abstract | Full Text Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses’ Health Study Claudia Trudel-Fitzgerald, Eric S Zhou, Elizabeth M Poole, Xuehong Zhang, Karin B Michels, A Heather Eliassen, Wendy Y Chen, Michelle D Holmes, Shelley S Tworoger and Eva S Schernhammer Br J Cancer 2017 116: 1239-1246; advance online publication, March 30, 2017; 10.1038/bjc.2017.85 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.